Dr. Pearlstone on Ongoing Research in Breast Cancer

David Pearlstone, MD

Published Online: Wednesday, March 16, 2011

David Pearlstone, M.D. Co-Division Chief, Breast Oncology from John Theurer Cancer Center, on important research taking place in the field of breast oncology.

SEE ALL VIDEOS FROM: David Pearlstone, MD

Related Articles

Geriatric Assessments Should Guide Treatment Decisions in Older Patients

Breast cancer clinicians today are faced with an ever-expanding number of older patients, yet determining the most appropriate treatment for these individuals can be challenging.

Resistance Poses Challenges in Chemotherapy Options

While chemotherapy might initially be effective in the treatment of patients with metastatic breast cancer, it is very common for patients to develop resistance to such agents.

LUX Program Examines Pan-HER Inhibitor Afatinib in Multiple Tumor Types

Researchers are attempting to determine if targeting more than one tyrosine kinase provide a greater benefit in several clinical trials involving the investigational drug afatinib.

Most Popular Right Now

Four Head and Neck Cancer Highlights From ASCO 2013

Pfizer Discontinues Late-Stage Trial of Inotuzumab Ozogamicin

Study Seeks to Eliminate Clinical Barriers to Bone Marrow Transplants

Resistance Poses Challenges in Chemotherapy Options

SGO Calls for Broad Changes in Managing Patient Care

Bringing the Oncology Community Together

Dr. Pearlstone on Ongoing Research in Breast Cancer